Cardiovascular innovation has entered a transformative era. The convergence of devices, digital tools, and data is no longer on the horizon—it’s here, reshaping how stakeholders invest, acquire, and scale. During a panel at LSI USA ’25, leaders from GE HealthCare, Mayo Clinic Ventures, Medtronic, and the American Heart Association broke down the three major forces influencing medical technology investment strategies across cardiovascular care: convergence, collaboration, and commercialization.